Latest news

  • Jonathan Coutinho, WP2 leider, bij omroep Max
  • CONTRAST2 annual meeting and Young talent meeting
  • Chi Nguyen defended her thesis!
  • New Publication from WP3c!
  • CONTRAST2 young talent travel grants call open
  • Home
  • News
    • Newsletters
  • Contact
  • Organization (investigators, collaborators and funders)
  • Data requests
  • Work packages info
    • WP1 – Preclinical and translational studies
    • WP2 – Pre-hospital stroke triage (PRESTIGE)
    • WP3a – MR CLEAN MeVO, Multicenter Randomized Clinical TriaL of Endovascular
    • WP3b – Carotid artery stenting during endovascular treatment for acute ischemic stroke (CASES)
    • WP3c – Improving Reperfusion strategies in Ischemic Stroke (IRIS)
    • WP4 – Dutch Intracerebral hemorrhage Surgery Trial (DIST); Minimally invasive endoscopy-guidedsurgery for intracerebral hemorrhage
    • WP5 – Neuroprotection
    • WP6 – SAfety oF Endovascular devices for Treatment of recently ruptured aneurYsms(SAFETY)
    • WP7 – The Dutch regIstry for endoVascular therapy IN ischaemic stroke with imaging Evaluation (DIVINE)
    • WP8 – Monitoring & improving long-term outcomes after stroke
    • WP9 – Modelling of Care and Treatment
    • WP10 – Research infrastructure for data management (clinical, imaging, biobank)
    • WP11 – Management & Communication
    • WP12 – Young Talent Development
  • Young Research Program
    • Young talent research travel grant
  • Documents
  • Ongoing studies
    • DIVINE
      • Rationale and aim
      • Study design
      • Study protocol and documents
      • Study progress
      • Organization
      • Contact
      • DIVINE Inclusieformulier
    • MEASURE
      • Rationale and aim
      • Study design
      • Study protocol and documents
      • Study progress
      • MEASURE include patient
    • CASES
    • DUTCH-ICH
  • Closed trials
    • MR CLEAN Trial
      • MR CLEAN publications
      • MR CLEAN contact
    • MR PREDICTS
    • MR CLEAN-R registry
      • Summary
    • MR ASAP
      • MR ASAP Rationale and aim
      • MR ASAP Study design
      • MR ASAP Trial organization
      • MR ASAP Contact
      • MR ASAP Trial progress
    • MR CLEAN LATE
      • MR CLEAN LATE Rationale and aim
      • MR CLEAN LATE Study design
      • MR CLEAN LATE Trial protocol
      • MR CLEAN LATE Trial organzation
      • MR CLEAN LATE Progress of the trial
      • MR CLEAN LATE Contact
      • MR CLEAN LATE Extended Follow-Up
    • MR CLEAN MED
      • MR CLEAN MED Rationale and aim
      • MR CLEAN MED Study design
      • MR CLEAN MED Organization
      • MR CLEAN MED Progress of the trial
      • MR CLEAN MED Trial protocol
    • MR CLEAN NOIV
      • MR CLEAN NOIV Rationale and aim
      • MR CLEAN NOIV Organization
      • MR CLEAN NOIV Study design
      • MR CLEAN NOIV Trial progress
      • MR CLEAN NOIV Contact
      • MR CLEAN NOIV IRIS
  • Links
  • Social media

Newsletters

Newsletter CONTRAST Q3-2024

Newsletter CONTRAST Q1-2024

Newsletter CONTRAST 03-2022

Newsletter CONTRAST 12-2021

Newsletter CONTRAST 09-2021

Newsletter CONTRAST 06-2021

Newsletter CONTRAST 03-2021

Newsletter CONTRAST 12-2020

Newsletter CONTRAST 09-2020

Newsletter CONTRAST 06-2020

Newsletter CONTRAST 03-2020

Extra newsletter WP5 Biobank

Newsletter CONTRAST 12-2019

Newsletter CONTRAST 12-2019

Newsletter CONTRAST 09-2019

Newsletter CONTRAST 06-2019

Newsletter CONTRAST 04-2019

Newsletter CONTRAST 12-2018